TARDBP and Alzheimer disease: In addition, TDP-43 inclusion bodies are found in more than half of AD patients, most often in the structures of the limbic system and, similarly to the co-deposition of alpha-synuclein, lead to more rapid rates of cognitive decline when compared to “pure” AD patients.